Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jun;39(6):696–699. doi: 10.1111/j.1365-2125.1995.tb05731.x

The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis.

J C Wetsteyn 1, P J De Vries 1, B Oosterhuis 1, C J Van Boxtel 1
PMCID: PMC1365086  PMID: 7654492

Abstract

The pharmacokinetics of chloroquine were studied in healthy volunteers who received one of three different multiple-dose regimens for 3 weeks: once weekly 300 mg, twice weekly 200 mg and once daily 50 mg chloroquine. Plasma concentrations of chloroquine and metabolites were determined by h.p.l.c. with fluorescence detection. The concentration-time course was fitted to a multiple-dose pharmacokinetic model. Volume of distribution, elimination half-life and clearance were not different for the three regimens, ranging from 250-302 l kg-1, 374-479 h and 0.44-0.58 l h-1 kg-1 respectively. After the first week of all dosage regimens, peak and trough concentrations of chloroquine were above 16 micrograms l-1, sufficiently suppressive for chloroquine-sensitive P. falciparum strains. These data suggest that once daily chloroquine could be combined with proguanil in a single tablet and should improve compliance when given for malaria chemoprophylaxis.

Full text

PDF
696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basco L. K., Ringwald P., Simon F., Doury J. C., Le Bras J. Evolution of chloroquine resistance in central and west Africa. Trop Med Parasitol. 1993 Jun;44(2):111–112. [PubMed] [Google Scholar]
  2. Bergqvist Y., Frisk-Holmberg M. Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography. J Chromatogr. 1980 Nov 14;221(1):119–127. doi: 10.1016/s0378-4347(00)81013-0. [DOI] [PubMed] [Google Scholar]
  3. Brohult J., Rombo L., Sirleaf V., Bengtsson E. The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications. Ann Trop Med Parasitol. 1979 Oct;73(5):401–405. doi: 10.1080/00034983.1979.11687279. [DOI] [PubMed] [Google Scholar]
  4. Fogh S., Jepsen S., Effersøe P. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans R Soc Trop Med Hyg. 1979;73(2):228–229. doi: 10.1016/0035-9203(79)90220-7. [DOI] [PubMed] [Google Scholar]
  5. Gozal D., Hengy C., Fadat G. Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance. Antimicrob Agents Chemother. 1991 Feb;35(2):373–376. doi: 10.1128/aac.35.2.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Oosterhuis B., Van den Berg M., Wetsteyn J., Van Boxtel C. J. HPLC-analysis and preliminary pharmacokinetic parameter estimations of chloroquine. Pharm Weekbl Sci. 1981 Dec 18;3(6):263–267. [PubMed] [Google Scholar]
  7. Phillips-Howard P. A., Blaze M., Hurn M., Bradley D. J. Malaria prophylaxis: survey of the response of British travellers to prophylactic advice. Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):932–934. doi: 10.1136/bmj.293.6552.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rombo L., Bergqvist Y., Hellgren U. Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis. Bull World Health Organ. 1987;65(6):879–883. [PMC free article] [PubMed] [Google Scholar]
  9. Wernsdorfer W. H. The development and spread of drug-resistant malaria. Parasitol Today. 1991 Nov;7(11):297–303. doi: 10.1016/0169-4758(91)90262-m. [DOI] [PubMed] [Google Scholar]
  10. Wetsteyn J. C., de Geus A. Chloroquine-resistant falciparum malaria imported into the Netherlands. Bull World Health Organ. 1985;63(1):101–108. [PMC free article] [PubMed] [Google Scholar]
  11. Wetsteyn J. C., de Geus A. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa. BMJ. 1993 Oct 23;307(6911):1041–1043. doi: 10.1136/bmj.307.6911.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. White N. J., Watt G., Bergqvist Y., Njelesani E. K. Parenteral chloroquine for treating falciparum malaria. J Infect Dis. 1987 Feb;155(2):192–201. doi: 10.1093/infdis/155.2.192. [DOI] [PubMed] [Google Scholar]
  13. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978 Apr;6(2):165–175. doi: 10.1007/BF01117450. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES